Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States

Our objective was to evaluate the factors associated with regional variation of rheumatoid arthritis (RA) disease burden in the US.

[1]  Thomas J. Wang,et al.  Geographic Inequalities in Cardiovascular Mortality in the United States: 1999 to 2018. , 2021, Mayo Clinic proceedings.

[2]  R. Buchbinder,et al.  Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis , 2020, The Journal of Rheumatology.

[3]  J. Curtis,et al.  Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry , 2020, The Journal of Rheumatology.

[4]  J. Curtis,et al.  Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available , 2020, Arthritis Research & Therapy.

[5]  Patrick M. Wilson,et al.  Neighborhood socioeconomic disadvantage is associated with multimorbidity in a geographically-defined community , 2020, BMC Public Health.

[6]  O. Olopade,et al.  Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis , 2019, JCO global oncology.

[7]  M. Weinblatt,et al.  Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study , 2020, Arthritis care & research.

[8]  E. Kang,et al.  Association between socioeconomic status and comorbidities among patients with rheumatoid arthritis: results of a nationwide cross-sectional survey. , 2019, Rheumatology.

[9]  William R. Buckingham,et al.  Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. , 2018, The New England journal of medicine.

[10]  E. Roughead,et al.  The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System , 2018, BMJ Open.

[11]  Li Wang,et al.  Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs , 2018, Rheumatology advances in practice.

[12]  A. Araujo,et al.  Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014 , 2017, Rheumatology International.

[13]  J. Kremer,et al.  The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights , 2017, Pharmacoepidemiology and drug safety.

[14]  Brad Wright,et al.  At Federally Funded Health Centers, Medicaid Expansion Was Associated With Improved Quality Of Care. , 2017, Health affairs.

[15]  K. Liao,et al.  Rheumatology Informatics System for Effectiveness: A National Informatics‐Enabled Registry for Quality Improvement , 2016, Arthritis care & research.

[16]  S. Seabury,et al.  Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis , 2016, Journal of managed care & specialty pharmacy.

[17]  M. Hochberg,et al.  Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events , 2015, Arthritis & rheumatology.

[18]  Carmen DeNavas-Walt,et al.  Income and Poverty in the United States: 2013 , 2014 .

[19]  J. Kremer,et al.  Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis. , 2013, The American journal of medicine.

[20]  Jinoos Yazdany,et al.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice , 2012, Arthritis care & research.

[21]  Stephen G. Martin,et al.  Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study , 2012, Annals of the rheumatic diseases.

[22]  D. Scott,et al.  Co-morbidities in established rheumatoid arthritis. , 2011, Best practice & research. Clinical rheumatology.

[23]  Christine Y. Lu,et al.  Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. , 2011, Journal of clinical epidemiology.

[24]  D. Symmons,et al.  Association of Functional Outcome With Both Personal- and Area-Level Socioeconomic Inequalities in Patients With Inflammatory Polyarthritis , 2009, Arthritis and rheumatism.

[25]  T. Pincus,et al.  RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories , 2008, The Journal of Rheumatology.

[26]  F. Wolfe,et al.  Comorbidities in rheumatoid arthritis. , 2007, Best practice & research. Clinical rheumatology.

[27]  D. Labarthe,et al.  Regional differences in African Americans' high risk for stroke: the remarkable burden of stroke for Southern African Americans. , 2007, Annals of epidemiology.

[28]  J. Smolen,et al.  The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.

[29]  Anne E Sales,et al.  Construction and Characteristics of the RxRisk-V: A VA-Adapted Pharmacy-Based Case-mix Instrument , 2003, Medical care.

[30]  Anne E Sales,et al.  Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population , 2003, Medical care.

[31]  J. Sundquist,et al.  Cardiovascular risk factors and the neighbourhood environment: a multilevel analysis. , 1999, International journal of epidemiology.

[32]  D. Commerce.  Statistical abstract of the United States , 1978 .